Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme
Titel:
Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme
Auteur:
Metro, Giulio Fabi, Alessandra Mirri, Maria A. Vidiri, Antonello Pace, Andrea Carosi, Mariantonia Russillo, Michelangelo Maschio, Marta Giannarelli, Diana Pellegrini, Domenica Pompili, Alfredo Cognetti, Francesco Carapella, Carmine M.